Yoshihiro Ikura

Takatsuki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

PTEN and PIK3CA Mutation Positive Breast Neuroendocrine Carcinoma Treated with Molecularly Targeted Therapy Including Capivasertib.

PTEN and PIK3CA Mutation Positive Breast Neuroendocrine Carcinoma Treated with Molecularly Targeted Therapy Including Capivasertib.

Journal: The Tohoku journal of experimental medicine

Published: March 11, 2026

Biopsy-Confirmed Cerebral Amyloid Angiopathy-Related Inflammation With Absence of Cerebral Microbleeds on T2* and Detectable Only by Susceptibility-Weighted Imaging.

Biopsy-Confirmed Cerebral Amyloid Angiopathy-Related Inflammation With Absence of Cerebral Microbleeds on T2* and Detectable Only by Susceptibility-Weighted Imaging.

Journal: Cureus

Published: October 26, 2025

Hepatic Decompensation Caused by IgG4-positive Plasma Cell Infiltration Mimicking Sclerosing Cholangitis, Who Achieved a Four-year Survival by Glucocorticoid Treatment.

Hepatic Decompensation Caused by IgG4-positive Plasma Cell Infiltration Mimicking Sclerosing Cholangitis, Who Achieved a Four-year Survival by Glucocorticoid Treatment.

Journal: Internal medicine (Tokyo, Japan)

Published: August 27, 2025

Plasma Fibulin-5 as a Novel Marker for Advanced Fibrosis in Chronic Hepatitis C.

Plasma Fibulin-5 as a Novel Marker for Advanced Fibrosis in Chronic Hepatitis C.

Journal: Gastro hep advances

Published: November 20, 2024

Liver biopsy in the post-hepatitis C virus era in Japan.

Liver biopsy in the post-hepatitis C virus era in Japan.

Journal: World journal of gastroenterology

Published: December 26, 2023

Change in Main Histological Type of Invasive Breast Cancer From Ductal to Lobular Carcinoma by Neoadjuvant Chemotherapy.

Change in Main Histological Type of Invasive Breast Cancer From Ductal to Lobular Carcinoma by Neoadjuvant Chemotherapy.

Journal: Cureus

Published: August 20, 2023

A Case Report of Rectal MiNEN Surgical Resection

A Case Report of Rectal MiNEN Surgical Resection

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 22, 2023

Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study.

Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study.

Journal: BMJ open gastroenterology

Published: July 29, 2022

Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic Scores.

Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic Scores.

Journal: Gastro hep advances

Published: June 15, 2022

Disseminated granulomatous Pneumocystis jirovecii pneumonia masquerading as miliary tuberculosis.

Disseminated granulomatous Pneumocystis jirovecii pneumonia masquerading as miliary tuberculosis.

Journal: Infection

Published: April 04, 2022

Limited dorsal myeloschisis without extradural stalk continuity to coexisting congenital dermal sinus.

Limited dorsal myeloschisis without extradural stalk continuity to coexisting congenital dermal sinus.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: February 24, 2022

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study.

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study.

Journal: EBioMedicine

Published: February 16, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026